Literature DB >> 23775717

Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.

Bartlomiej Przychodzen1, Andres Jerez, Kathryn Guinta, Mikkael A Sekeres, Richard Padgett, Jaroslaw P Maciejewski, Hideki Makishima.   

Abstract

Recently, recurrent mutations of spliceosomal genes were frequently identified in myeloid malignancies, as well as other types of cancers. One of these spliceosomal genes, U2AF1, was affected by canonical somatic mutations in aggressive type of myeloid malignancies. We hypothesized that U2AF1 mutations causes defects of splicing (missplicing) in specific genes and that such misspliced genes might be important in leukemogenesis. We analyzed RNA deep sequencing to compare splicing patterns of 201 837 exons between the cases with U2AF1 mutations (n = 6) and wild type (n = 14). We identified different alternative splicing patterns in 35 genes comparing cells with mutant and wild-type U2AF1. U2AF1 mutations are associated with abnormal splicing of genes involved in functionally important pathways, such as cell cycle progression and RNA processing. In addition, many of these genes are somatically mutated or deleted in various cancers. Of note is that the alternative splicing patterns associated with U2AF1 mutations were associated with specific sequence signals at the affected splice sites. These novel observations support the hypothesis that U2AF1 mutations play a significant role in myeloid leukemogenesis due to selective missplicing of tumor-associated genes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775717      PMCID: PMC3739042          DOI: 10.1182/blood-2013-01-480970

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.

Authors:  Sarah Abu Kar; Anna Jankowska; Hideki Makishima; Valeria Visconte; Andres Jerez; Yuka Sugimoto; Hideki Muramatsu; Fabiola Traina; Manuel Afable; Kathryn Guinta; Ramon V Tiu; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Seiji Kojima; Mikkael A Sekeres; Alan F List; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Sequence logos: a new way to display consensus sequences.

Authors:  T D Schneider; R M Stephens
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Structure of PTB bound to RNA: specific binding and implications for splicing regulation.

Authors:  Florian C Oberstrass; Sigrid D Auweter; Michèle Erat; Yann Hargous; Anke Henning; Philipp Wenter; Luc Reymond; Batoul Amir-Ahmady; Stefan Pitsch; Douglas L Black; Frédéric H-T Allain
Journal:  Science       Date:  2005-09-23       Impact factor: 47.728

4.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

Authors:  Yasuhito Nannya; Masashi Sanada; Kumi Nakazaki; Noriko Hosoya; Lili Wang; Akira Hangaishi; Mineo Kurokawa; Shigeru Chiba; Dione K Bailey; Giulia C Kennedy; Seishi Ogawa
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.

Authors:  Andrew J Dunbar; Lukasz P Gondek; Christine L O'Keefe; Hideki Makishima; Manjot S Rataul; Hadrian Szpurka; Mikkael A Sekeres; Xiao Fei Wang; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.

Authors:  Sudhakar Sivasubramaniam; Xuemin Sun; Yen-Ru Pan; Shaohui Wang; Eva Y-H P Lee
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

7.  Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

Authors:  Lukasz P Gondek; Ramon Tiu; Christine L O'Keefe; Mikkael A Sekeres; Karl S Theil; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-22       Impact factor: 22.113

8.  Mechanism and thermodynamics of binding of the polypyrimidine tract binding protein to RNA.

Authors:  Nathan Schmid; Bojan Zagrovic; Wilfred F van Gunsteren
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

Review 9.  Splicing in disease: disruption of the splicing code and the decoding machinery.

Authors:  Guey-Shin Wang; Thomas A Cooper
Journal:  Nat Rev Genet       Date:  2007-08-29       Impact factor: 53.242

10.  Structure of tandem RNA recognition motifs from polypyrimidine tract binding protein reveals novel features of the RRM fold.

Authors:  M R Conte; T Grüne; J Ghuman; G Kelly; A Ladas; S Matthews; S Curry
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

View more
  80 in total

1.  U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.

Authors:  A Tefferi; C M Finke; T L Lasho; E A Wassie; R Knudson; R P Ketterling; C A Hanson; A Pardanani
Journal:  Leukemia       Date:  2013-10-07       Impact factor: 11.528

Review 2.  Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.

Authors:  Jermaine L Jenkins; Clara L Kielkopf
Journal:  Trends Genet       Date:  2017-03-31       Impact factor: 11.639

Review 3.  Transcriptome protection by the expanded family of hnRNPs.

Authors:  Urmi Das; Hai Nguyen; Jiuyong Xie
Journal:  RNA Biol       Date:  2019-01-06       Impact factor: 4.652

Review 4.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

Authors:  A Sveen; S Kilpinen; A Ruusulehto; R A Lothe; R I Skotheim
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

Review 5.  Genomic tools in acute myeloid leukemia: From the bench to the bedside.

Authors:  Brian S White; John F DiPersio
Journal:  Cancer       Date:  2014-01-28       Impact factor: 6.860

6.  MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.

Authors:  Velizar Shivarov; Anna Dolnik; Katharina M Lang; Jan Krönke; Florian Kuchenbauer; Peter Paschka; Verena I Gaidzik; Hartmut Döhner; Richard F Schlenk; Konstanze Döhner; Lars Bullinger
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

Review 7.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing.

Authors:  Yeon Lee; Donald C Rio
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

Review 8.  Splicing factor gene mutations in hematologic malignancies.

Authors:  Borja Saez; Matthew J Walter; Timothy A Graubert
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

9.  Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia.

Authors:  Ruijun Jeanna Su; Brian A Jonas; Jeanna Welborn; Jeffrey Paul Gregg; Mingyi Chen
Journal:  Hum Pathol (N Y)       Date:  2016-09

Review 10.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.